Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Zhao, Hui ^a   Gu, Xiaomeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Human esophageal squamous cell carcinoma; IGF 1r; Radiation sensitivity; RNAi

Indexed keywords

ANTINEOPLASTIC AGENT; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; TUMOR MARKER;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVERALL SURVIVAL; RADIOSENSITIVITY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; EVALUATION STUDY; GENE SILENCING; GENETICS; NUDE MOUSE; RADIATION DOSE; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, NUDE; RADIATION TOLERANCE; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84920824239     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-325     Document Type: Article

References (20)

1. Shang L, Wang M: Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Front Med 2013, 7:401-410.
2. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H: Epidemiology of esophageal cancer in Japan and China. J Epidemiol 2013, 23:233-242.
3. Thallinger CM, Kiesewetter B, Raderer M, Hejna M: Pre-and postoperative treatment modalities for esophageal squamous cell carcinoma. Anticancer Res 2012, 32:4609-4627.
4. Stoner GD, Wang LS, Chen T: Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 2007, 224:337-349.
5. Nakajima M, Kato H: Treatment options for esophageal squamous cell carcinoma. Expert Opin Pharmacother 2013, 14:1345-1354.
6. Xie L, Song X, Yu J, Wei L, Song B, Wang X, Lv L: Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Exp Clin Cancer Res 2009, 28:68.
7. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y: Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 2012, 18:5144-5153.
8. Wang XC, Tian LL, Tian J, Li D, Wang Y, Wu H, Zheng H, Meng AM: Overexpression of Cks1 increases the radiotherapy resistance of esophageal squamous cell carcinoma. J Radiat Res 2012, 53:72-78.
9. Chen J, Kwong DL, Cao T, Hu Q, Zhang L, Ming X, Chen J, Fu L, Guan X: Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis Esophagus 2013, 10:12088.
10. Bellini MF, Silva AE, Varella-Garcia M: Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques. Genet Mol Biol 2010, 33:205-213.
11. He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D: Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. Cancer Sci 2009, 100:1591-1596.
12. Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH: Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2012, 144:1352-1359.
13. Arcaro A: Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol 2013, 4:30.
14. Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, Reynolds JV, Pidgeon GP, Lysaght J: IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol 2012, 107:196-204.
15. Imsumran A, Adachi Y, Yamamoto H, Li R, Wang Y, Min Y, Piao W, Nosho K, Arimura Y, Shinomura Y, Hosokawa M, Lee CT, Carbone DP, Imai K: Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma. Carcinogenesis 2007, 28:947-956.
16. Adachi Y, Ohashi H, Imsumran A, Yamamoto H, Matsunaga Y, Taniguchi H, Nosho K, Suzuki H, Sasaki Y, Arimura Y, Carbone DP, Imai K, Shinomura Y: The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma. Tumour Biol 2014, 35:973-985.
17. Luo M, Shen D, Zhou X, Chen X, Wang W: MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013, 153:836-847.
18. Sukka-Ganesh B, Mohammed KA, Kaye F, Goldberg EP, Nasreen N: Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene. BMC Cancer 2013, 12:309.
19. Fernandez MC, Martin A, Venara M, Calcagno Mde L, Sansó G, Quintana S, Chemes HE, Barontini M, Pennisi PA: Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas. Clin Endocrinol (Oxf ) 2013, 79:623-630.
20. Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S, Angouridakis N, Vlachtsis K, Nikolaou A, Konstantinidis I, Fountzilas G: Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer. PLoS One 2013, 8:e54048.